[Retracted] Identification of the Novel Methylated Genes’ Signature to Predict Prognosis in INRG High-Risk Neuroblastomas

Figure 3

Patients with neuroblastoma have a methylated gene signature that predicts overall survival. (a) KMS curves were used for dividing the patients into high- and low-risk groups. Log-rank tests were used to calculate values. (b) Results of receiver operating characteristic (ROC) analysis.

(a)

(b)

(c)

(d)